July 25, 2016 3:22 AM ET

Biotechnology

Company Overview of VBI Vaccines Inc

Key Executives for VBI Vaccines Inc

NameBoard RelationshipsTitleAge
Jeff R. Baxter FCMA25 RelationshipsChief Executive Officer, President and Director55
Francisco Diaz-Mitoma M.D., Ph.D.10 RelationshipsFounder--
James J. Martin CPA, MBA No RelationshipsChief Financial Officer49

VBI Vaccines Inc Board Members*

NameBoard RelationshipsPrimary CompanyAge
Steven S. Gillis M.D., Ph.D. 148 RelationshipsArch Venture Partners, L.P.62
Jeff R. Baxter FCMA 25 RelationshipsVBI Vaccines, Inc.55
Scott Requadt J.D., MBA 17 RelationshipsPhoenix Strategy Investments, LLC48
Alan P. Timmins 17 RelationshipsYamhill Valley Vineyards Inc.56
Stanley A. Plotkin M.D. 86 RelationshipsMymetics Corporation83
View All Board Members

VBI Vaccines Inc Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Alan P. Timmins17 Relationships3 Executives
Compensation Committee J.D., MBAScott Requadt17 Relationships2 Executives
Nominating Committee M.D., Ph.D.Steven S. Gillis148 Relationships3 Executives
Corporate Governance Committee M.D., Ph.D.Steven S. Gillis148 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$400.0K
400.0K
381.0K
Bonus$180.0K
180.0K
261.1K
Total Short Term Compensation
Not meaningful
Total Value of Options$580.0K
580.0K
34.2M
Compensation as of Fiscal Year 2015
VBI Vaccines Inc CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Cleveland BioLabs, Inc. Announces Executive Changes
July 22, 2016 8:22 PM ET
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas Reed as M. D, Effective July 21, 2016
July 22, 2016 8:18 PM ET
ContraFect Corporation Appoints Steven C. Gilman as President and Chief Executive Officer
July 21, 2016 9:32 PM ET
William R. Ringo Intends to Resign from Mirati Therapeutics, Inc.'s Board of Directors
July 21, 2016 8:03 PM ET
Biostage Appoints Harout Dersimonian as Chief Scientific Officer to Oversee Cell Biology, Materials Science and Other Research Underlying its Organ Implant Development
July 21, 2016 12:56 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VBI Vaccines Inc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.